Netoglitazone

This classification denotes an anti-diabetic agent with the molecular formula C21H16FNO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) QOV2JZ647A, chemically known as 2,4-thiazolidinedione, 5-((6-((2-fluorophenyl)methoxy)-2-naphthalenyl)methyl)- but more generally known as netoglitazone, which bears US NIH Compound Identifier 204109. The term NETOGLITAZONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16., No. 1.2002, List 47). Most nations, for tariff and trade purposes, schedule netoglitazone under HS 29341000 and SITC 51579. As of Q4 2014, NETOGLITAZONE remains US FDA's Preferred Term for this commodity. Netoglitazone bears US NLM identifiers UMLS ID C1721279 and NCI Concept Code C72822. SMILES: C1=CC=C(C(=C1)COC2=CC3=C(C=C2)C=C(C=C3)CC4C(=O)NC(=O)S4)F.